RP 1.25 > (Ramipril 1.25 mg)
Pill imprint RP 1.25 > has been identified as Ramipril 1.25 mg.
Ramipril is used in the treatment of high blood pressure; left ventricular dysfunction; diabetic kidney disease; cardiovascular risk reduction; heart attack (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Ramipril 1.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- RP 1.25 >
- Strength:
- 1.25 mg
- Color:
- White & Yellow
- Size:
- 14.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Cobalt Laboratories Inc
- National Drug Code (NDC):
- 16252-0570
- Inactive Ingredients:
- corn starch
gelatin
titanium dioxide
ferric oxide yellow
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0294 | Amerisource Health Services |
| 54868-5896 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More about ramipril
Consumer resources
- Other brands: Altace
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
